Medical policy
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…
Local and national coverage reference guide
Learn how to locate local and national coverage information regarding local coverage determinations (LCDs) and national coverage determinations (NCDs).
Local and national coverage reference guide
Learn how to locate local and national coverage information regarding local coverage determinations (LCDs) and national coverage determinations (NCDs).
New FastTrack to Medicare coverage policies tool
Do you find it challenging to identify a Medicare coverage policy concerning a particular item or service? Not sure what to do if a Medicare coverage policy doesn’t exist? A new FastTrack to Medicare…
New FastTrack to Medicare coverage policies tool
Do you find it challenging to identify a Medicare coverage policy concerning a particular item or service? Not sure what to do if a Medicare coverage policy doesn’t exist? A new FastTrack to Medicare…
Inappropriate billing of anesthesia services for epidural steroid injections (ESI) and facet joint injections for pain management
The Office of Inspector General (OIG) conducted a nationwide audit identifying Medicare Part B payments to physicians for anesthesia administered during selected spinal pain management (SPM)…
The local coverage determination (LCD) development process
General information on the local coverage development (LCD) process.
The local coverage determination (LCD) development process
General information on the local coverage development (LCD) process.